Clinical trials

  • Ketoprofen for Postoperative pain after cardiac surgery
  • BLEXIMENIB for Acute Myeloid Leukemia
  • Palazestrant / OP-1250 for Estrogen receptor–positive (ER+), HER2-negative advanced/metastatic breast cancer
  • BOTENSILIMAB for Gastric cancer (MSI-H/dMMR)|Gastro-oesophageal junction adenocarcinoma (MSI-H/dMMR)|Oesophageal adenocarcinoma (MSI-H/dMMR)
  • AMIVANTAMAB for Non-small cell lung cancer | EGFR-mutated non-small cell lung cancer
  • Anhydrous lidocaine hydrochloride for Glaucoma
  • Dexamethasone for Endotoxemia-induced systemic inflammatory response
  • TARLATAMAB for Limited-stage small cell lung cancer
  • FINERENONE for Type 1 diabetes
  • ABBV-400 for Locally advanced or metastatic solid tumors
  • DOSTARLIMAB for Recurrent endometrial cancer | Advanced endometrial cancer (Stage III/IV)
  • POVORCITINIB for Nonsegmental vitiligo